Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.

@article{Scheuch2007AnticoagulativeEO,
  title={Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.},
  author={Gerhard Scheuch and Peter John GlaxoSmithKline Brand and Thomas Meyer and Christine Herpich and Bernhard Muellinger and Jakub Brom and Gottfried Weidinger and Martin Kohlh{\"a}ufl and Karl Haeussinger and Michael Spannagl and Wolfgang Schramm and Ruediger Siekmeier},
  journal={Journal of physiology and pharmacology : an official journal of the Polish Physiological Society},
  year={2007},
  volume={58 Suppl 5 Pt 2},
  pages={
          603-14
        }
}
Inhalation of heparin results in local antiinflammatory and antifibrotic effects and an inhibition of blood coagulation. A number of experimental and clinical studies demonstrated that inhalant administration of heparin or low molecular weight heparin (LMWH) is a feasible and save tool for anticoagulative treatment. However, heparin and LMWH differ in respect to their molecular weight, pulmonary absorption, and principle of their anticoagulative pattern. In our study we investigated the… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS

Inhalational use of antithrombotics in humans: Review of the literature.

  • Thrombosis research
  • 2015
VIEW 16 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Treatment of systemic diseases by inhalation of biomolecule aerosols.

  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • 2009

Systemic treatment by inhalation of macromolecules--principles, problems, and examples.

  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • 2008
VIEW 2 EXCERPTS